Project

AIDA, the AI solution to fight gastric cancer

AIDA (Artificially Intelligent Diagnostic Assistant) is a multidisciplinary AI-powered assistant, that helps clinicians diagnose precancerous inflammation, suggests personalised therapeutic strategies for medical treatment and follow-up, and makes personalised recommendations for monitoring patient health status, thus contributing to gastric cancer prevention.

How it works

Data and AI-based solutions enable a shift in this disease management.

Platform

We provide a secure and federated data & AI platform enabling our partners to make data accessible to others following a privacy-preserving approach

  • Secure collaboration enclaves for partners to make data accessible while preserving data privacy
  • Easy physical and virtual ingestion and harmonisation of data following commonly accepted standards part of UMLS
  • Collaborative analytics and AI model building using self-service machine learning tools and federated learning techniques
  • Automation of licensing and IP management
  • Sharing of analytics and AI solutions with any other partner and healthcare actor
target audience

Who is using AIDA?

Researchers understand the chronic inflammation factors triggering the health-to-disease transition and subsequently provide optimal counselling to citizens for improving their health.

Healthcare professionals have the scientific evidence and understanding of health-to-disease transition to develop and use improved guidelines for personalised prevention strategies to tackle chronic diseases.

Citizens adopt healthier lifestyles and behaviours, make healthier choices and maintain longer a healthy, independent and active life with a reduced disease burden, including at old ages or in other vulnerable stages of life.

Spread the word!

In order to make our research accessible to everyone, you can easily download a free documentation of AIDA. No registration needed.

AIDA Partner SERMAS/FIBHUP at AEG 2026 in Madrid

The AIDA consortium is proud to highlight the outstanding participation of our partner SERMAS/FIBHUP at the 29th Annual Meeting of the Spanish Association of Gastroenterology (AEG 2026), one of Spain’s leading scientific events in digestive health.

Behind the scenes

The project is led by Tania Fleitas from INCLIVA Biomedical Institute (Spain), is supported by over 7 million euros between European and British funding. The consortium involves 15 centres of excellence from 8 European countries.

Contact form

Get in touch with us

Are you interested in knowing more about the project?